ESMO Gastrointestinal Cancers Congress 2024

ESMO Gastrointestinal Cancers Congress 2024

Location: Munich

Lugano, Switzerland, 14 June 2024 – The European Society for Medical Oncology is pleased to announce the ESMO Gastrointestinal Cancers Congress 2024, the scientific congress entirely dedicated to the presentation of advances and discussions around the prevention, diagnosis and management of malignancies of the gastrointestinal tract.

The event will take place in Munich, Germany, between 26-29 June and will include a virtual component to give everyone the opportunity to attend.

The full congress programme is available online together with abstracts and late-breaking abstract titles, covering educational sessions on state-of-the-art treatment options, trending topics such as the early onset of GI malignancies and the application of precision medicine for better management of patients.

Below are some highlights helpful to easily navigate the programme:

- Phase-3 clinical trials with potential practice changing results in:

  • advanced gastric and gastroesophageal cancer (LBA3, LBA4)

  • rare GI cancers (211MO)

  • biliary cancer (279MO)

- Facilitate the early detection of hepatocellular carcinoma through innovative approaches, including the use of artificial intelligence (165MO, 181P)

- Novel insights in the role of precision medicine in GI cancer (session on Friday, 28 June, 11:15-12:45)

- New data on the molecular characteristics of early onset of GI cancers (Session on Thursday, 27 June, 16:30-18:00, 80P, 132P, 139P, 140P, 291P, 365P)

- The crucial role of multidisciplinary tumour boards to manage complex GI cancers cases and define the best treatment strategies for the patients (sessions on Wednesday, 26 June, 14:30-16:00, Thursday, 27 June, 8:30-9:30, Friday, 28 June, 8:30-10:00).

Keynote Lecture

The results of 549 studies will be presented and published online as a supplement to Annals of Oncology.

Press conference

Ahead of the event, on the morning of Wednesday, 26 June, accredited press representatives will have the opportunity to listen to and ask questions to GI oncology experts during a press conference, reserved to accredited journalists. Further details will be released soon. In the meantime, please make sure to submit your request for accreditation before Tuesday, 25 June.

Press accreditation

ESMO welcomes press representatives working for recognised press outlets interested in obtaining information and reporting on cancer issues, upon presentation of a letter of assignment and a valid press card. Press representatives are required to observe and abide by the ESMO Policy on Press Activities. To apply for press accreditation, please fill out the form available here. Requests for press accreditation should be sent by Tuesday, 25 June. Please be kindly informed that onsite press accreditation will not be possible.

Third Parties Media registration

Third Party Media representatives and Filming Crews not eligible as press must abide by the ESMO Policy on Media Activities Organised by Third Parties and can request a Third Parties Media badge through (cc

Further information

ESMO Press Office

Regions: Europe, Switzerland
Keywords: Health, Medical, Public Dialogue - health


For well over a decade, in my capacity as a researcher, broadcaster, and producer, I have relied heavily on Alphagalileo.
All of my work trips have been planned around stories that I've found on this site.
The under embargo section allows us to plan ahead and the news releases enable us to find key experts.
Going through the tailored daily updates is the best way to start the day. It's such a critical service for me and many of my colleagues.
Koula Bouloukos, Senior manager, Editorial & Production Underknown
We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet

We Work Closely With...

  • BBC
  • The Times
  • National Geographic
  • The University of Edinburgh
  • University of Cambridge
Copyright 2024 by AlphaGalileo Terms Of Use Privacy Statement